Alzheimer’s disease (AD) is common and highly heritable with many gene variants associated with it. However, the genetic risk for AD have not been clearly delineated, with the stage of Alzheimer’s before symptoms show estimated to last over a decade. Given that current clinical trials are testing whether therapies can slow memory and thinking decline among people at risk for![]()
